A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)
Top Cited Papers
Open Access
- 6 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Military Medical Research
- Vol. 7 (1), 1-23
- https://doi.org/10.1186/s40779-020-0233-6
Abstract
In December 2019, a new type viral pneumonia cases occurred in Wuhan, Hubei Province; and then named “2019 novel coronavirus (2019-nCoV)” by the World Health Organization (WHO) on 12 January 2020. For it is a never been experienced respiratory disease before and with infection ability widely and quickly, it attracted the world’s attention but without treatment and control manual. For the request from frontline clinicians and public health professionals of 2019-nCoV infected pneumonia management, an evidence-based guideline urgently needs to be developed. Therefore, we drafted this guideline according to the rapid advice guidelines methodology and general rules of WHO guideline development; we also added the first-hand management data of Zhongnan Hospital of Wuhan University. This guideline includes the guideline methodology, epidemiological characteristics, disease screening and population prevention, diagnosis, treatment and control (including traditional Chinese Medicine), nosocomial infection prevention and control, and disease nursing of the 2019-nCoV. Moreover, we also provide a whole process of a successful treatment case of the severe 2019-nCoV infected pneumonia and experience and lessons of hospital rescue for 2019-nCoV infections. This rapid advice guideline is suitable for the first frontline doctors and nurses, managers of hospitals and healthcare sections, community residents, public health persons, relevant researchers, and all person who are interested in the 2019-nCoV.Keywords
This publication has 20 references indexed in Scilit:
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common MarmosetThe Journal of Infectious Diseases, 2015
- Development and Validation of Severe Hypoxemia Associated Risk Prediction Model in 1,000 Mechanically Ventilated Patients*Critical Care Medicine, 2015
- Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare FacilitiesInfection & Chemotherapy, 2015
- Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort studyThe Lancet Infectious Diseases, 2014
- Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaquesNature Medicine, 2013
- Acute Respiratory Distress SyndromeJAMA, 2012
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Treatment of severe acute respiratory syndromeEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- [Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy].2004
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004